Xi Xia

2.0k total citations
34 papers, 1.3k citations indexed

About

Xi Xia is a scholar working on Molecular Biology, Immunology and Microbiology. According to data from OpenAlex, Xi Xia has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Microbiology. Recurrent topics in Xi Xia's work include Antimicrobial Peptides and Activities (6 papers), Immune Response and Inflammation (5 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Xi Xia is often cited by papers focused on Antimicrobial Peptides and Activities (6 papers), Immune Response and Inflammation (5 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Xi Xia collaborates with scholars based in China, United States and Indonesia. Xi Xia's co-authors include Yizhen Wang, Deguang Song, Haiwen Zhang, Yifan Liu, Liang Xu, Feifei Han, Yanhong Zhou, Xin Zong, Zhenfei Sun and Kai Shi and has published in prestigious journals such as The Journal of Immunology, Biomaterials and Cancer Research.

In The Last Decade

Xi Xia

34 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xi Xia China 21 727 305 247 218 140 34 1.3k
Francesco M. Mancuso Spain 19 789 1.1× 218 0.7× 175 0.7× 126 0.6× 142 1.0× 42 1.6k
Qiong Zhao China 21 670 0.9× 135 0.4× 100 0.4× 150 0.7× 83 0.6× 63 1.2k
Yi Kong China 20 712 1.0× 90 0.3× 129 0.5× 102 0.5× 101 0.7× 96 1.4k
Vongthip Souvannavong France 19 521 0.7× 259 0.8× 62 0.3× 371 1.7× 94 0.7× 36 1.2k
Juan G. Cárcamo Chile 21 365 0.5× 103 0.3× 99 0.4× 376 1.7× 80 0.6× 61 1.3k
Jinting Li China 19 601 0.8× 241 0.8× 39 0.2× 123 0.6× 134 1.0× 80 1.1k
T. William Jordan New Zealand 23 717 1.0× 181 0.6× 73 0.3× 103 0.5× 114 0.8× 72 1.5k
Jingjing Zhou China 25 1.0k 1.4× 783 2.6× 61 0.2× 94 0.4× 85 0.6× 82 1.8k
Misako U. Sampaio Brazil 27 1.1k 1.5× 407 1.3× 53 0.2× 135 0.6× 100 0.7× 82 1.7k
Jong‐Young Kwak South Korea 26 852 1.2× 95 0.3× 87 0.4× 578 2.7× 202 1.4× 57 1.9k

Countries citing papers authored by Xi Xia

Since Specialization
Citations

This map shows the geographic impact of Xi Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Xia more than expected).

Fields of papers citing papers by Xi Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Xia. The network helps show where Xi Xia may publish in the future.

Co-authorship network of co-authors of Xi Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Xi Xia. A scholar is included among the top collaborators of Xi Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Xia. Xi Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Xinghua, Gehua Wen, Xue Wu, et al.. (2022). Ketamine promotes the amyloidogenic pathway by regulating endosomal pH. Toxicology. 471. 153163–153163. 5 indexed citations
2.
Xia, Xi, Yu Chen, Lin Wang, et al.. (2020). Synthesis of diosgenyl quaternary ammonium derivatives and their antitumor activity. Steroids. 166. 108774–108774. 11 indexed citations
3.
Yan, Qingqing, Xi Xia, Zhenfei Sun, & Yuda Fang. (2017). Depletion of Arabidopsis SC35 and SC35-like serine/arginine-rich proteins affects the transcription and splicing of a subset of genes. PLoS Genetics. 13(3). e1006663–e1006663. 86 indexed citations
4.
Lu, Zeqing, Yifan Liu, Xi Xia, et al.. (2016). Cathelicidin-BF ameliorates lipopolysaccharide-induced intestinal epithelial barrier disruption in rat. Life Sciences. 152. 199–209. 33 indexed citations
5.
Xia, Xi, Lin Zhang, & Yizhen Wang. (2015). The antimicrobial peptide cathelicidin-BF could be a potential therapeutic for Salmonella typhimurium infection. Microbiological Research. 171. 45–51. 41 indexed citations
6.
Zong, Xin, et al.. (2015). LFP-20, a porcine lactoferrin peptide, ameliorates LPS-induced inflammation via the MyD88/NF-κB and MyD88/MAPK signaling pathways. Developmental & Comparative Immunology. 52(2). 123–131. 40 indexed citations
7.
Zhang, Shuai, Xiang Li, Shuai Shao, et al.. (2015). Antagonism between phytohormone signalling underlies the variation in disease susceptibility of tomato plants under elevated CO2. Journal of Experimental Botany. 66(7). 1951–1963. 104 indexed citations
8.
Han, Feifei, Haiwen Zhang, Xi Xia, et al.. (2015). Porcine β-Defensin 2 Attenuates Inflammation and Mucosal Lesions in Dextran Sodium Sulfate–Induced Colitis. The Journal of Immunology. 194(4). 1882–1893. 135 indexed citations
9.
Huang, Jin, Desheng Xiao, Guanghui Li, et al.. (2013). EphA2 promotes epithelial–mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells. Oncogene. 33(21). 2737–2747. 173 indexed citations
10.
Liu, Ronghua, Xiangyi Ma, Hongyan Wang, et al.. (2013). The novel fusion protein sTRAIL-TMTP1 exhibits a targeted inhibition of primary tumors and metastases. Journal of Molecular Medicine. 92(2). 165–175. 20 indexed citations
11.
Fan, Liangsheng, Hongyan Wang, Xi Xia, et al.. (2012). Loss of E-cadherin promotes prostate cancer metastasis via upregulation of metastasis-associated gene 1 expression. Oncology Letters. 4(6). 1225–1233. 34 indexed citations
12.
Liu, Ronghua, Ling Xi, Danfeng Luo, et al.. (2012). Enhanced targeted anticancer effects and inhibition of tumor metastasis by the TMTP1 compound peptide TMTP1-TAT-NBD. Journal of Controlled Release. 161(3). 893–902. 39 indexed citations
13.
Liu, Yifan, Xi Xia, Liang Xu, & Yizhen Wang. (2012). Design of hybrid β-hairpin peptides with enhanced cell specificity and potent anti-inflammatory activity. Biomaterials. 34(1). 237–250. 121 indexed citations
14.
Deng, Yuxuan, Xiaoyan Cao, Xiang Luo, et al.. (2012). Blocking p55PIK signaling inhibits proliferation and induces differentiation of leukemia cells. Cell Death and Differentiation. 19(11). 1870–1879. 28 indexed citations
15.
Fang, Yong, Yi Hu, Peng Wu, et al.. (2011). Synergistic Efficacy in Human Ovarian Cancer Cells by Histone Deacetylase Inhibitor TSA and Proteasome Inhibitor PS-341. Cancer Investigation. 29(4). 247–252. 4 indexed citations
16.
Wang, Wei, Xi Xia, Shusen Wang, et al.. (2011). Oncolytic adenovirus armed with human papillomavirus E2 gene in combination with radiation demonstrates synergistic enhancements of antitumor efficacy. Cancer Gene Therapy. 18(11). 825–836. 9 indexed citations
17.
Hong, Zhenya, Zhiqiang Han, Min Xiao, et al.. (2009). Microarray study of mechanism of trichostatin a inducing apoptosis of Molt-4 cells. Journal of Huazhong University of Science and Technology [Medical Sciences]. 29(4). 445–450. 4 indexed citations
18.
Gao, Qinglei, Fei Ye, Xi Xia, et al.. (2009). Correlation between PTEN expression and PI3K/Akt signal pathway in endometrial carcinoma. Journal of Huazhong University of Science and Technology [Medical Sciences]. 29(1). 59–63. 24 indexed citations
19.
Weng, Danhui, Xiaohong Song, Hui Xing, et al.. (2008). Implication of the Akt2/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells. Cancer Letters. 273(2). 257–265. 40 indexed citations
20.
Wu, Huijuan, Shixuan Wang, Hui Xing, et al.. (2008). Reversal of the malignant phenotype of ovarian cancer A2780 cells through transfection with wild-type PTEN gene. Cancer Letters. 271(2). 205–214. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026